A federal jury in northern Indiana hit Johnson & Johnson with a $35 million verdict in a lawsuit over an “unreasonably dangerous” pelvic mesh implant, a team of lawyers has announced.
After two weeks of trial, the nine-person jury in U.S. District Court for the Northern District of Indiana on Friday rendered its verdict against J&J and its subsidiary, Ethicon, for the manufacture, marketing and recruitment of physicians to install the Prolift mesh device intended for repairing prolapsed pelvic organs.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]